Personalized medicine of patients with respiratory infections through the measurement of specific blood biomarkers: fact or fiction?

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. Epub 2016 Feb 24.
   PubMed Web of Science ®Google Scholar
• Mitsuma SF, Mansour MK, Dekker JP, et al. Promising new assays and technologies for the diagnosis and management of infectious diseases. Clin Infect Dis. 2013;56(7):996–1002. Epub 2012 Dec 12.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Litke A, Albrich WC, et al. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis. 2013;26(2):159–167. Epub 2013 Feb 26.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther. 2010;8(5):575–587. Epub 2010 May 12.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Aujesky D, Muller C, et al. Biomarker-guided personalised emergency medicine for all – hope for another hype? Swiss Med Wkly. 2015;145:w14079. Epub 2015 Feb 20.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections – hope for hype? Swiss Med Wkly. 2009;139(23–24):318–326. Epub 2009 Jun 17.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA. 2013;309(7):717–718. Epub 2013 Feb 21.
   PubMed Web of Science ®Google Scholar
• Sager R, Kutz A, Mueller B, et al. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med. 2017;15(1):15. Epub 2017 Jan 25.
   PubMed Web of Science ®Google Scholar
• Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426–435. Epub 2013 Feb 5.
   PubMed Web of Science ®Google Scholar
• Müller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest. 2010;138(1):121–129. Epub 2010 Mar 20.
   PubMed Web of Science ®Google Scholar
• Laukemann S, Kasper N, Kulkarni P, et al. Can we reduce negative blood cultures with clinical scores and blood markers? Results from an observational cohort study. Medicine (Baltimore). 2015;94(49):e2264. Epub 2015 Dec 15.
   PubMed Web of Science ®Google Scholar
• de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819–827. Epub 2016 Mar 8.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250. Epub 1997 Jan 23.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Hausfater P, Amin D, et al. Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study. Crit Care. 2015;19:377. Epub 2015 Oct 30.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Wolbers M, Christ-Crain M, et al. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care. 2010;14(3):R106. Epub 2010 Jun 10.
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Schuetz P, Müller B. Biomarkers in the management of pneumonia. Expert Rev Respir Med. 2008;2(5):565–572. Epub 2008 Oct 1.
   PubMedGoogle Scholar
• Grolimund E, Kutz A, Marlowe RJ, et al. Long-term prognosis in COPD exacerbation: role of biomarkers, clinical variables and exacerbation type. COPD. 2015;12(3):295–305. Epub 2014 Sep 18.
   PubMedGoogle Scholar
• Alan M, Grolimund E, Kutz A, et al. Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study. J Int Med. 2015;278(2):174–184. Epub 2014 Dec 23.
   PubMed Web of Science ®Google Scholar
• Nickler M, Schaffner D, Christ-Crain M, et al. Prospective evaluation of biomarkers for prediction of quality of life in community-acquired pneumonia. Clin Chem Lab Med. 2016;54(11):1831–1846. Epub 2016 Apr 22.
   PubMed Web of Science ®Google Scholar
• Nickler M, Ottiger M, Steuer C, et al. Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections. Respir Res. 2015;16(1):125. Epub 2015 Oct 17.
   PubMed Web of Science ®Google Scholar
• Vögeli A, Ottiger M, Meier MA, et al. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia. Respir Res. 2017;18(1):25. Epub 2017 Jan 25.
   PubMed Web of Science ®Google Scholar
• Meier MA, Ottiger M, Vögeli A, et al. Activation of the tryptophan/serotonin pathway is associated with severity and predicts outcomes in pneumonia: results of a long-term cohort study. Clin Chem Lab Med. 2017. Epub 2017 Jan 12.
   PubMed Web of Science ®Google Scholar
• Ottiger M, Nickler M, Steuer C, et al. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease. Eur J Int Med. 2016;36:67–73. Epub 2016 Aug 28.
   PubMed Web of Science ®Google Scholar
• Wirz SA, Blum CA, Schuetz P, et al. Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia. Eur Respir J. 2016;48(4):1150–1159. Epub 2016 Jul 30.
   PubMed Web of Science ®Google Scholar
• Popovic M, Blum CA, Nigro N, et al. Benefit of adjunct corticosteroids for community-acquired pneumonia in diabetic patients. Diabetologia. 2016;59(12):2552–2560. Epub 2016 Sep 12.
   PubMed Web of Science ®Google Scholar
• Blum CA, Briel M, Schuetz P, et al. Corticosteroid therapy for pneumonia – author’s reply. Lancet. 2015;386(9997):956. Epub 2015 Sep 16.
   PubMed Web of Science ®Google Scholar
• Nickler M, Ottiger M, Steuer C, et al. Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study. Crit Care. 2017;21(1):72. Epub 2017 Mar 25.
   PubMed Web of Science ®Google Scholar
• Albrich WC, Rüegger K, Dusemund F, et al. Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial. Eur Respir J. 2013;42(4):1064–1075. Epub 2013 Jan 26.
   PubMed Web of Science ®Google Scholar